Package 70860-211-74

Brand: fulvestrant

Generic: fulvestrant
NDC Package

Package Facts

Identity

Package NDC 70860-211-74
Digits Only 7086021174
Product NDC 70860-211
Product ID 70860-211_2cc985f3-36aa-f803-e063-6394a90a06f1
Description

2 SYRINGE, GLASS in 1 CARTON (70860-211-74) / 5 mL in 1 SYRINGE, GLASS (70860-211-41)

Marketing

Marketing Status
Discontinued 2026-12-31
Brand fulvestrant
Generic fulvestrant
Sample Package No

Linked Drug Pages (1)

Fulvestrant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "2cc985f3-36aa-f803-e063-6394a90a06f1", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["8ed06e0e-c17b-4c71-8d03-888bcde4a638"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Athenex Pharmaceutical Division, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (70860-211-74)  / 5 mL in 1 SYRINGE, GLASS (70860-211-41)", "package_ndc": "70860-211-74", "marketing_end_date": "20261231", "marketing_start_date": "20200218"}], "brand_name": "Fulvestrant", "product_id": "70860-211_2cc985f3-36aa-f803-e063-6394a90a06f1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "70860-211", "generic_name": "fulvestrant", "labeler_name": "Athenex Pharmaceutical Division, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fulvestrant", "active_ingredients": [{"name": "FULVESTRANT", "strength": "50 mg/mL"}], "application_number": "ANDA211422", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20200218"}